Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28621
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGramnea I.en
dc.contributor.authorHudson F.en
dc.contributor.authorD'costa R.en
dc.contributor.authorMcevoy L.en
dc.contributor.authorSasadeusz J.en
dc.contributor.authorGopal B.en
dc.contributor.authorKausman J.en
dc.contributor.authorMasterson R.en
dc.contributor.authorPaizis K.en
dc.contributor.authorKanellis J.en
dc.contributor.authorHughes P.en
dc.contributor.authorGoodman D.en
dc.contributor.authorWhitlam J.en
dc.contributor.authorLee D.en
dc.contributor.authorSeng N.en
dc.date.accessioned2021-05-14T09:38:27Zen
dc.date.available2021-05-14T09:38:27Zen
dc.date.copyright2020en
dc.date.created20210119en
dc.date.issued2021-01-19en
dc.identifier.citationNephrology. Conference: 55th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, ANZSN 2020. Virtual. 25 (SUPPL 3) (pp 12), 2020. Date of Publication: December 2020.en
dc.identifier.issn1440-1797en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/28621en
dc.description.abstractAims: To review the Victorian increased viral risk donor (IVRD) program 22 months post-implementation. Background(s): IVRDs with at-risk behaviours for blood borne virus infection and negative nucleic acid testing (NAT) have a low absolute risk of window period infection but were historically under-utilised. A new system of allocation of these donors (defined by Public Health Service [PHS] 2013 criteria and open window periods) to pre-consented recipients was developed. Method(s): We retrospectively examined the characteristics of IVRDs (July 31 2018-May 31, 2020). Data for comparison with non-IVRDs was available for the first 7 months. Continuous data was expressed as median (IQR). Result(s): 40% of waitlisted recipients were pre-consented to accept IVRD kidneys. Thirty-two IVRDs (58 kidneys) were utilised, comprising 13.5% of all kidney donors. Only 9% of allocated IVRDs had neither kidney accepted. Injecting drug use (59%) was the commonest at-risk behaviour. NAT was performed 3 (2-4) days post-admission. 9 (28%) IVRDs had positive HCV Ab but negative NAT. 50% of recipients of these 9 IVRDs developed abnormal HCV serology, but no viraemia was detected in any IVRD recipients to date at 1 and 3 months post-transplantation. 3-month eGFR (CKD-EPI) was 65 (53-79) mL/min/1.73 m2. Compared with non-IVRDs, IVRDs were younger (37 (30-44) vs 51 (35-61) years; P < 0.01), with lower kidney donor profile index (KDPI) (26 (17-40) vs 59 (25-78); P < 0.001), and none had a KDPI >80% (0% vs 19%; P < 0.05). Waiting time was significantly shorter for blood group O IVRD vs non-IVRD recipients (26 (18-29) vs 38 (34-42) months; P = 0.001). Conclusion(s): IVRDs appear to offer better quality kidneys and may reduce waiting time with no transmission to date. Increasing the pre-consent rate may improve utilisation and benefit more waitlisted recipients.en
dc.languageenen
dc.languageEnglishen
dc.publisherBlackwell Publishingen
dc.titleSuccessful implementation of increased viral risk donor waiting list for preconsented waitlisted recipients in victoria.en
dc.typeConference Abstracten
dc.identifier.affiliationNephrologyen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/nep.13797en
local.date.conferencestart2020-11-28en
dc.identifier.source633927639en
dc.identifier.institution(Lee) Department of Renal Medicine, Eastern Health Clinical School, Monash University (Lee, Paizis, Whitlam) Department of Nephrology, Austin Health (Seng, Gramnea, D'costa, Mcevoy) DonateLife Victoria (Hudson) Victorian Transplantation and Immunogenetics Service, Australian Red Cross Lifeblood (Sasadeusz) Department of Infectious Diseases, Royal Melbourne Hospital (Gopal) Department of Renal Medicine, Alfred Hospital (Kausman) Department of Nephrology, Royal Children's Hospital (Masterson, Hughes) Department of Nephrology, Royal Melbourne Hospital (Kanellis) Department of Nephrology, Monash Health (Goodman) Department of Nephrology, St Vincent's Hospital Melbourneen
dc.description.addressD. Lee, Department of Renal Medicine, Eastern Health Clinical School, Monash Universityen
dc.description.publicationstatusCONFERENCE ABSTRACTen
local.date.conferenceend2020-12-02en
dc.rights.statementCopyright 2021 Elsevier B.V., All rights reserved.en
dc.identifier.affiliationext(Lee) Department of Renal Medicine, Eastern Health Clinical School, Monash University-
dc.identifier.affiliationext(Lee, Paizis, Whitlam) Department of Nephrology, Austin Health-
dc.identifier.affiliationext(Seng, Gramnea, D'costa, Mcevoy) DonateLife Victoria-
dc.identifier.affiliationext(Hudson) Victorian Transplantation and Immunogenetics Service, Australian Red Cross Lifeblood-
dc.identifier.affiliationext(Sasadeusz) Department of Infectious Diseases, Royal Melbourne Hospital-
dc.identifier.affiliationext(Gopal) Department of Renal Medicine, Alfred Hospital-
dc.identifier.affiliationext(Kausman) Department of Nephrology, Royal Children's Hospital-
dc.identifier.affiliationext(Masterson, Hughes) Department of Nephrology, Royal Melbourne Hospital-
dc.identifier.affiliationext(Goodman) Department of Nephrology, St Vincent's Hospital Melbourne-
dc.identifier.affiliationmh(Kanellis) Department of Nephrology, Monash Health-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeConference Abstract-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
Appears in Collections:Conferences
Show simple item record

Page view(s)

18
checked on Sep 29, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.